Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_12894 | 84 | 1.75 | Mlig455_024418, Mlig455_024572 | Neo: - Age: - Region-enriched R2: 5.211/0.02671 |
SLC46A2 | Mlig455_024418 {REF} {Length: 2094} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_44254} {RNA815_43004} Mlig455_024572 {REF} {Length: 1344} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_71457} {RNA815_15082} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.689 | 1.718 | 0.99979 | 1.00000 | |
RegionR2 | 5.211 | 1.718 | 0.00134 | 0.02671 | |
RegionR3 | 1.513 | 1.718 | 0.24009 | 0.78146 | |
RegionR4 | 1.005 | 1.718 | 0.32672 | 0.64460 | |
RegionR5 | -0.873 | 1.718 | 0.99972 | 1.00000 | |
RegionR6 | -2.281 | 1.718 | 0.99972 | 1.00000 | |
RegionR7 | -2.215 | 1.718 | 0.99983 | 1.00000 | |
RegionR8 | -0.671 | 1.718 | 0.99991 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 5.327 | 1.718 | 0.29669 | 0.99329 | |
RegenerationR2 | -2.117 | 1.718 | 0.04707 | 0.35779 | |
RegenerationR3 | -0.12 | 1.718 | 0.88292 | 1.00000 | |
RegenerationR4 | 0.02 | 1.718 | 0.87337 | 1.00000 | |
RegenerationR5 | 1.626 | 1.718 | 0.16698 | 0.59347 | |
RegenerationR6 | 2.481 | 1.718 | 0.21476 | 0.55874 | |
RegenerationBL | -1.849 | 1.718 | 0.99992 | 1.00000 | |
RegenerationTP | 2.601 | 1.718 | 0.37207 | 0.80971 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_12894 | 84 | 1.75 | Mlig455_024418, Mlig455_024572 | Neo: - Age: - Region-enriched R2: 5.211/0.02671 |
SLC46A2 | 5 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | - | Mlig455_024418 {REF} {Length: 2094} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_44254} {RNA815_43004} Mlig455_024572 {REF} {Length: 1344} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_71457} {RNA815_15082} |
2. | MligTC455_19758 | 53 | 1.1 | Mlig455_002464 | Neo: - Age: - Region-enriched R2: 6.578/0.02863 |
3.654 | 0.976 | 0.904 | 0.858 | 0.916 | - | - | Mlig455_002464 {REF} {Length: 2549} {RNA1310_38437} {RNA815_40458} | |
3. | MligTC455_27684 | 8324 | 173.41 | Mlig455_067482, Mlig455_067490 | Neo: - Age: Down-Up-Up Region-specific R2: 3.632 Region-enriched R2: 2.544/0.00000 |
3.483 | 0.740 | - | 0.941 | 0.960 | 0.842 | - | Mlig455_067482 {REF} {Length: 709} {RNA1509_3821} {RNA1310_17576.1} {RNA815_6182.1} Mlig455_067490 {REF} {Length: 963} {RNA1509_20366, RNA1509_3821} {RNA1310_17576.1, RNA1509_20366, RNA1509_3821} {RNA1509_20366, RNA1509_3821, RNA815_6182.1} |
|
4. | MligTC455_15546 | 141 | 2.93 | Mlig455_021744 | Neo: - Age: - |
3.396 | 0.978 | 0.706 | - | 0.963 | 0.749 | - | Mlig455_021744 {REF} {Length: 1839} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=60.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.5]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=51.2, Expect=1e-06]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=72.0, Expect=3e-13]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=69.3, Expect=2e-12]} {Smed: dd_Smed_v6_25364_0_1, dd_Smed_v6_25364_0_1, [RH, Score=197, Expect=7e-59]} {RNA1310_26850} {RNA815_17444} | |
5. | MligTC455_02495 | 2759 | 57.47 | Mlig455_039292 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.530/0.00442 |
3.281 | 0.845 | 0.985 | 0.721 | 0.730 | - | - | Mlig455_039292 {REF} {Length: 910} {RNA1509_35923, RNA1509_4995, RNA1509_7740} {RNA1310_15694.2, RNA1509_35923, RNA1509_4995, RNA1509_7740} {RNA1509_35923, RNA1509_4995, RNA1509_7740, RNA815_5222} | |
6. | MligTC455_27785 | 115 | 2.39 | Mlig455_001141 | Neo: - |
HMCN2 | 2.91 | 1.000 | - | 0.919 | 0.991 | - | - | Mlig455_001141 {REF} {Length: 2156} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=6e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_38050} {RNA1310_19586} {RNA815_17693} |
7. | MligTC455_20532 | 63 | 1.32 | Mlig455_029971 | Neo: - Age: - |
2.896 | 1.000 | - | 0.913 | 0.983 | - | - | Mlig455_029971 {REF} {Length: 1702} {Pfam: UPF0489 domain [PF12640.9, score=20.3]} {RNA1509_3030} {RNA1310_35103} {RNA815_26539} | |
8. | MligTC455_25412 | 199 | 4.15 | Mlig455_008720, Mlig455_063581 | Neo: - Age: - Region-enriched R2: 7.484/0.00035 |
CNBD2 | 2.872 | 0.971 | - | 0.919 | 0.982 | - | - | Mlig455_008720 {REF} {Length: 2602} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.1]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=1e-69]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} Mlig455_063581 {REF} {Length: 2668} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.3]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=7e-70]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} |
9. | MligTC455_01421 | 9 | 0.2 | Mlig455_020111 | Neo: - Age: - |
2.869 | 1.000 | - | 0.886 | 0.983 | - | - | Mlig455_020111 {REF} {Length: 880} {Pfam: WSC domain [PF01822.21, score=53.2]; PAN domain [PF00024.28, score=20.6]} {RNA1509_53783} {RNA1310_34968.1} {RNA815_9084.1} | |
10. | MligTC455_08342 | 11 | 0.24 | Mlig455_069886 | Neo: - Age: - |
2.869 | 1.000 | - | 0.886 | 0.983 | - | - | Mlig455_069886 {REF} {Length: 980} {Pfam: WSC domain [PF01822.21, score=48.3]; PAN domain [PF00024.28, score=22.0]} {RNA1509_53783} {RNA1310_34968.1} {RNA815_24434} | |
11. | MligTC455_42647 | 262 | 5.45 | Mlig455_044411 | Neo: - Age: - Region-enriched R2: 3.002/0.01555 |
MEIS1 | 2.869 | 0.934 | - | 0.958 | 0.977 | - | - | Mlig455_044411 {REF} {Length: 3872} {Pfam: N-terminal of Homeobox Meis and PKNOX1 [PF16493.7, score=134.9]; Homeobox KN domain [PF05920.13, score=71.0]; Homeodomain [PF00046.31, score=32.6]} {Human: ENSG00000143995, MEIS1, Meis homeobox 1, [RH, Score=190, Expect=5e-53]; ENSG00000134138, MEIS2, Meis homeobox 2, [RH, Score=190, Expect=5e-53]} {Mouse: ENSMUSG00000020160, Meis1, Meis homeobox 1, [RH, Score=190, Expect=3e-53]; ENSMUSG00000027210, Meis2, Meis homeobox 2, [RH, Score=190, Expect=4e-53]} {Dmel: FBgn0001235, hth, homothorax, [Score=176, Expect=2e-50]} {Celegans: WBGene00006796, unc-62, Homeobox protein unc-62, [RH, Score=170, Expect=1e-45]} {Smed: dd_Smed_v6_6114_0_2, dd_Smed_v6_6114_0_2, [RH, Score=226, Expect=8e-66]} {RNA1509_22853} {RNA1310_27014} {RNA815_28484} |
12. | MligTC455_16199 | 114 | 2.37 | Mlig455_041013, Mlig455_041178 | Neo: Irradiation Age: - Region-enriched R2: 9.007/0.00037 |
2.867 | 0.994 | - | 0.890 | 0.983 | - | - | Mlig455_041013 {REF} {Length: 3381} {RNA1509_42904} {RNA1310_20434} {RNA815_22064} Mlig455_041178 {REF} {Length: 2722} {RNA1509_42904} {RNA1310_20004} {RNA815_22064} |
|
13. | MligTC455_45597 | 116 | 2.41 | Mlig455_049417 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.185/0.02405 |
2.866 | 0.962 | - | 0.932 | 0.972 | - | - | Mlig455_049417 {REF} {Length: 1106} {RNA1310_45744} {RNA815_56662} | |
14. | MligTC455_31240 | 329 | 6.85 | Mlig455_010150 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.167 Region-enriched R4: 6.247/0.01251 |
2.837 | 0.992 | - | 0.867 | 0.978 | - | - | Mlig455_010150 {REF} {Length: 557} {RNA1509_16524, RNA1509_26056} {RNA1310_74791.1, RNA1509_16524} {RNA1509_16524, RNA815_37646} | |
15. | MligTC455_35446 | 75 | 1.56 | Mlig455_031433 | Neo: - Age: Down-Up-Up |
2.834 | 0.953 | - | 0.943 | 0.938 | - | - | Mlig455_031433 {REF} {Length: 1430} {NoTransDecoderORF} {RNA1310_35373} {RNA815_22739} | |
16. | MligTC455_03731 | 113 | 2.35 | Mlig455_066791 | Neo: - Age: - |
2.826 | 0.968 | - | 0.871 | 0.987 | - | - | Mlig455_066791 {REF} {Length: 1679} {Smed: dd_Smed_v6_13648_0_1, dd_Smed_v6_13648_0_1, [RH, Score=79.7, Expect=2e-16]} {RNA1509_58026} {RNA1310_23180, RNA1509_58026} {RNA1509_58026, RNA815_34008} | |
17. | MligTC455_14519 | 25 | 0.51 | Mlig455_005304 | Neo: - Age: - |
2.816 | 1.000 | - | 0.856 | 0.960 | - | - | Mlig455_005304 {REF} {Length: 1686} {RNA1509_3030} {RNA1310_65512} {RNA815_48423} | |
18. | MligTC455_43557 | 362 | 7.55 | Mlig455_059172, Mlig455_065527 | Neo: - Age: Down-Down-Up Region-specific R2: 6.284 Region-enriched R2: 5.832/0.00001 |
ANKRD63 | 2.812 | 0.954 | - | 0.882 | 0.976 | - | - | Mlig455_059172 {REF} {Length: 1739} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.2]; Ankyrin repeats (many copies) [PF13637.8, score=42.6]; Ankyrin repeat [PF13606.8, score=27.6]; Ankyrin repeats (many copies) [PF13857.8, score=27.1]; Ankyrin repeat [PF00023.32, score=25.9]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=67.4, Expect=7e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=49.3, Expect=7e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=49.3, Expect=4e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_44826} {RNA815_62096} Mlig455_065527 {REF} {Length: 2998} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=52.3]; Ankyrin repeats (many copies) [PF13637.8, score=42.0]; Ankyrin repeats (many copies) [PF13857.8, score=26.7]; Ankyrin repeat [PF00023.32, score=26.0]; Ankyrin repeat [PF13606.8, score=22.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=68.2, Expect=6e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=50.1, Expect=5e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=50.4, Expect=2e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=80.9, Expect=2e-16]} {RNA1509_30872} {RNA1310_44826} {RNA815_62096} |
19. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 2.809 | 0.962 | 0.961 | 0.886 | - | - | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
20. | MligTC455_27186 | 28 | 0.57 | Mlig455_010236 | Neo: - Age: logFC(26M/2M)=-1.855 |
2.805 | 1.000 | - | 0.950 | 0.855 | - | - | Mlig455_010236 {REF} {Length: 486} {RNA1509_7146} {RNA1310_76234.2} {RNA815_34947.2} | |
21. | MligTC455_24951 | 220 | 4.58 | Mlig455_052169 | Neo: - Age: - Region-specific R2: 4.554 Region-enriched R2: 4.264/0.00008 Regeneration-downregulated R2: -1.743 Regeneration-depleted R2: -1.743 |
CCDC169 | 2.803 | 0.983 | - | 0.899 | 0.921 | - | - | Mlig455_052169 {REF} {Length: 1369} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
22. | MligTC455_20529 | 56 | 1.18 | Mlig455_005302 | Neo: - |
2.802 | 1.000 | - | 0.811 | 0.991 | - | - | Mlig455_005302 {REF} {Length: 1691} {RNA1509_3030} {RNA1310_35103} {RNA815_26539} | |
23. | MligTC455_22212 | 1732 | 36.09 | Mlig455_009239, Mlig455_009645, Mlig455_037058 | Neo: - Age: logFC(26M/2M)=-0.722 Region-specific R2: 6.329 Region-enriched R2: 6.728/0.00000 |
LMNA | 2.795 | 0.916 | - | 0.887 | 0.992 | - | - | Mlig455_009239 {REF} {Length: 2842} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_009645 {REF} {Length: 2337} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_037058 {REF} {Length: 4944} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1310_9741.1, RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1509_18286, RNA1509_31019, RNA1509_37437, RNA815_3167} |
24. | MligTC455_29238 | 48 | 1.01 | Mlig455_063305 | Neo: - Age: - |
2.793 | - | 0.933 | 0.891 | 0.969 | - | - | Mlig455_063305 {REF} {Length: 892} {TRANSSPLICED} {RNA1310_67367} {RNA815_37220} | |
25. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 2.792 | 0.903 | - | 0.911 | 0.978 | - | - | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
26. | MligTC455_24952 | 637 | 13.28 | Mlig455_054178, Mlig455_060727 | Neo: - Age: Down-Up-Down Region-specific R2: 4.165 Region-enriched R2: 3.160/0.00003 Regeneration-downregulated BL: -4.774 Regeneration-depleted BL: -4.774 |
CCDC169 | 2.775 | 0.972 | - | 0.882 | 0.921 | - | - | Mlig455_054178 {REF} {Length: 1390} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} Mlig455_060727 {REF} {Length: 1391} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029, RNA1509_8270} {RNA1509_8270, RNA815_11545} |
27. | MligTC455_31463 | 20 | 0.42 | Mlig455_057169 | Neo: - Age: - |
2.77 | 1.000 | - | 0.890 | 0.880 | - | - | Mlig455_057169 {REF} {Length: 1647} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=39.0]} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=82.4, Expect=3e-18]} {RNA1509_6604} {RNA1310_43619} {RNA815_6128.2} | |
28. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 2.767 | - | 0.976 | 0.886 | 0.905 | - | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
29. | MligTC455_20381 | 53 | 1.1 | Mlig455_032565 | Neo: - Age: - Region-enriched R4: 10.544/0.00002 Regeneration-downregulated R4: -7.191 Regeneration-depleted R4: -7.191 |
2.76 | 0.914 | - | 0.871 | 0.975 | - | - | Mlig455_032565 {REF} {Length: 719} {RNA1509_48296, RNA1509_48731} {RNA1310_86641, RNA1509_48731} {RNA1509_48731, RNA815_40392} | |
30. | MligTC455_46502 | 168 | 3.5 | Mlig455_010557 | Neo: - Age: - |
2.759 | 0.926 | - | 0.861 | 0.972 | - | - | Mlig455_010557 {REF} {Length: 557} {Pfam: HalX domain [PF08663.12, score=24.3]} {RNA1509_57107} {RNA1310_80026, RNA1509_57107} {RNA1509_57107, RNA815_41799} | |
31. | MligTC455_40051 | 36 | 0.76 | Mlig455_025990 | Neo: - Age: logFC(26M/2M)=-0.633 |
PRKCE | 2.756 | 0.991 | - | 0.829 | 0.936 | - | - | Mlig455_025990 {REF} {Length: 2622} {Pfam: Protein kinase domain [PF00069.27, score=102.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=69.5]; Kinase-like [PF14531.8, score=19.5]} {Human: ENSG00000171132, PRKCE, protein kinase C epsilon, [Score=84.3, Expect=1e-16]} {Mouse: ENSMUSG00000045038, Prkce, protein kinase C, epsilon, [Score=82.0, Expect=5e-16]} {Dmel: FBgn0283472, S6k, Ribosomal protein S6 kinase, [Score=79.0, Expect=2e-15]} {Celegans: WBGene00009793, pkn-1, Protein Kinase N (PKN) homolog, [Score=73.2, Expect=2e-13]} {Smed: dd_Smed_v6_8010_0_1, dd_Smed_v6_8010_0_1, [Score=77.8, Expect=4e-15]} {RNA1509_36146} {RNA1310_24732} {RNA815_64704} |
32. | MligTC455_51029 | 340 | 7.09 | Mlig455_056736 | Neo: - |
2.753 | 0.989 | - | 0.983 | 0.781 | - | - | Mlig455_056736 {REF} {Length: 850} {RNA1509_4527} {RNA1310_27536} {RNA815_19650} | |
33. | MligTC455_37988 | 67 | 1.41 | Mlig455_008561 | Neo: - Age: - Region-enriched R2: 8.988/0.00000 |
2.728 | 0.902 | - | 0.859 | 0.967 | - | - | Mlig455_008561 {REF} {Length: 3146} {Pfam: EF-hand domain pair [PF13499.8, score=36.5]; EF-hand domain [PF13405.8, score=31.2]; EF hand [PF00036.34, score=29.3]; EF-hand domain pair [PF13833.8, score=20.4]; EF hand [PF13202.8, score=19.4]} {Smed: dd_Smed_v6_1010_0_1, dd_Smed_v6_1010_0_1, [Score=104, Expect=1e-26]} {RNA1310_31713.1} {RNA815_36423} | |
34. | MligTC455_11958 | 26 | 0.54 | Mlig455_035540 | Neo: - Age: - |
2.727 | 0.858 | - | 0.886 | 0.983 | - | - | Mlig455_035540 {REF} {Length: 976} {RNA1509_48973} {RNA1310_39954.1} {RNA815_19596} | |
35. | MligTC455_15726 | 270 | 5.63 | Mlig455_031204 | Neo: - Age: - Region-enriched R2: 6.820/0.00015 |
ADAMTS18 | 2.715 | 0.978 | - | 0.932 | 0.805 | - | - | Mlig455_031204 {REF} {Length: 2405} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=77.6]; Metallo-peptidase family M12 [PF13688.8, score=52.5]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=45.6]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=41.4]; ADAM cysteine-rich domain [PF17771.3, score=40.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=30.9]; Astacin (Peptidase family M12A) [PF01400.26, score=19.3]} {Human: ENSG00000140873, ADAMTS18, ADAM metallopeptidase with thrombospondin type 1 motif 18, [Score=90.9, Expect=1e-18]} {Mouse: ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=90.1, Expect=1e-18]; ENSMUSG00000053399, Adamts18, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18, [Score=89.7, Expect=2e-18]} {Dmel: FBgn0034903, sona, sol narae, [RH, Score=114, Expect=7e-27]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [RH, Score=100, Expect=2e-22]} {RNA1509_42775} {RNA1310_19585.1, RNA1509_42775} {RNA1509_42775, RNA815_17997} |
36. | MligTC455_16311 | 89 | 1.86 | Mlig455_053827, Mlig455_068518 | Neo: - Age: - Region-enriched R2: 5.249/0.01530 |
CALML3 | 2.713 | 0.989 | - | 0.978 | 0.746 | - | - | Mlig455_053827 {REF} {Length: 1659} {Pfam: EF-hand domain pair [PF13499.8, score=64.3]; EF hand [PF00036.34, score=58.1]; EF-hand domain [PF13405.8, score=55.1]; EF hand [PF13202.8, score=37.9]; EF-hand domain pair [PF13833.8, score=32.8]; EF-hand domain [PF14658.8, score=20.4]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=96.7, Expect=3e-25]; ENSG00000143933, CALM2, calmodulin 2, [Score=96.7, Expect=6e-25]; ENSG00000198668, CALM1, calmodulin 1, [Score=96.3, Expect=3e-25]; ENSG00000160014, CALM3, calmodulin 3, [Score=96.3, Expect=3e-25]} {Mouse: ENSMUSG00000036438, Calm2, calmodulin 2, [Score=96.3, Expect=2e-25]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=96.3, Expect=2e-25]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=96.3, Expect=2e-25]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=95.9, Expect=2e-25]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=97.1, Expect=7e-26]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=97.4, Expect=5e-26]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=97.4, Expect=4e-26]} {RNA1509_37850} {RNA1310_5623.1} {RNA815_35579} Mlig455_068518 {REF} {Length: 1007} {Pfam: EF-hand domain pair [PF13499.8, score=64.3]; EF hand [PF00036.34, score=58.1]; EF-hand domain [PF13405.8, score=55.1]; EF hand [PF13202.8, score=38.0]; EF-hand domain pair [PF13833.8, score=33.0]; EF-hand domain [PF14658.8, score=20.4]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=96.7, Expect=2e-25]; ENSG00000143933, CALM2, calmodulin 2, [Score=96.7, Expect=6e-25]; ENSG00000160014, CALM3, calmodulin 3, [Score=96.3, Expect=3e-25]; ENSG00000198668, CALM1, calmodulin 1, [Score=96.3, Expect=3e-25]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=96.3, Expect=2e-25]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=96.3, Expect=2e-25]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=96.3, Expect=2e-25]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=95.9, Expect=3e-25]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=97.1, Expect=7e-26]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=97.1, Expect=5e-26]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=97.1, Expect=4e-26]} {RNA1509_37850} {RNA1310_5623.1} {RNA815_35579} |
37. | MligTC455_33538 | 789 | 16.45 | Mlig455_051129, Mlig455_051205 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.262 Region-specific R2: 4.638 Region-enriched R2: 3.952/0.00052 |
LRRIQ4 | 2.711 | 0.864 | - | 0.868 | 0.979 | - | - | Mlig455_051129 {REF} {Length: 1662} {Pfam: Leucine rich repeat [PF13855.8, score=77.3]; Leucine Rich repeats (2 copies) [PF12799.9, score=61.4]} {Human: ENSG00000188306, LRRIQ4, leucine rich repeats and IQ motif containing 4, [Score=95.5, Expect=6e-21]; ENSG00000240720, LRRD1, leucine rich repeats and death domain containing 1, [Score=93.6, Expect=4e-20]; ENSG00000130224, LRCH2, leucine rich repeats and calponin homology domain containing 2, [Score=93.2, Expect=4e-20]; ENSG00000163827, LRRC2, leucine rich repeat containing 2, [Score=92.4, Expect=2e-20]; ENSG00000033122, LRRC7, leucine rich repeat containing 7, [Score=91.7, Expect=2e-19]} {Mouse: ENSMUSG00000070056, Mfhas1, malignant fibrous histiocytoma amplified sequence 1, [Score=115, Expect=9e-28]} {Dmel: FBgn0033984, Lap1, [Score=86.3, Expect=4e-18]} {Celegans: WBGene00002632, let-413, [Score=90.5, Expect=1e-19]} {Smed: dd_Smed_v6_17742_0_1, dd_Smed_v6_17742_0_1, [RH, Score=360, Expect=1e-124]} {RNA1509_30762} {RNA1310_31301} {RNA815_15435} Mlig455_051205 {REF} {Length: 2514} {Pfam: Leucine rich repeat [PF13855.8, score=72.4]; Leucine Rich repeats (2 copies) [PF12799.9, score=59.1]} {Human: ENSG00000188306, LRRIQ4, leucine rich repeats and IQ motif containing 4, [Score=94.7, Expect=1e-20]; ENSG00000130224, LRCH2, leucine rich repeats and calponin homology domain containing 2, [Score=93.2, Expect=4e-20]; ENSG00000240720, LRRD1, leucine rich repeats and death domain containing 1, [Score=92.8, Expect=6e-20]; ENSG00000163827, LRRC2, leucine rich repeat containing 2, [Score=92.4, Expect=2e-20]; ENSG00000033122, LRRC7, leucine rich repeat containing 7, [Score=91.3, Expect=3e-19]} {Mouse: ENSMUSG00000070056, Mfhas1, malignant fibrous histiocytoma amplified sequence 1, [Score=115, Expect=1e-27]} {Dmel: FBgn0033984, Lap1, [Score=85.5, Expect=9e-18]} {Celegans: WBGene00002632, let-413, [Score=90.5, Expect=1e-19]} {Smed: dd_Smed_v6_17742_0_1, dd_Smed_v6_17742_0_1, [RH, Score=362, Expect=2e-125]} {RNA1509_30762} {RNA1310_31301, RNA1509_30762} {RNA1509_30762, RNA815_15435} |
38. | MligTC455_52507 | 60 | 1.26 | Mlig455_016440 | Neo: - Age: - Region-enriched R2: 5.871/0.01204 |
2.709 | 0.907 | 0.961 | 0.841 | - | - | - | Mlig455_016440 {REF} {Length: 1576} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1310_98267} | |
39. | MligTC455_43676 | 56 | 1.16 | Mlig455_058053, Mlig455_058096 | Neo: - Age: - |
2.705 | 1.000 | - | 0.988 | 0.717 | - | - | Mlig455_058053 {REF} {Length: 391} {NoTransDecoderORF} {RNA1509_25254} {RNA1310_102705} {RNA815_52459} Mlig455_058096 {REF} {Length: 1983} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=51.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=90.1, Expect=1e-19]} {RNA1509_1472} {RNA1310_25467} {RNA815_39314} |
|
40. | MligTC455_37338 | 40 | 0.84 | Mlig455_035280 | Neo: - Age: - |
2.7 | 0.982 | - | 0.797 | 0.921 | - | - | Mlig455_035280 {REF} {Length: 2442} {RNA1310_17149} {RNA815_15957} | |
41. | MligTC455_27786 | 197 | 4.11 | Mlig455_001303 | Neo: - Age: Up-Down-Down Region-specific R2: 6.990 Region-enriched R2: 6.421/0.02381 |
HMCN2 | 2.696 | 0.808 | - | 0.895 | 0.993 | - | - | Mlig455_001303 {REF} {Length: 2154} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.5]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=5e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_4579} {RNA1310_19586} {RNA815_17693} |
42. | MligTC455_32563 | 900 | 18.74 | Mlig455_021721 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.879 Region-enriched R2: 4.965/0.00011 |
2.695 | 0.969 | - | 0.891 | 0.835 | - | - | Mlig455_021721 {REF} {Length: 1079} {RNA1509_570} {RNA1310_40828} {RNA815_5866.1} | |
43. | MligTC455_51028 | 379 | 7.9 | Mlig455_013974, Mlig455_034999 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.689 Region-enriched R2: 4.550/0.00627 |
2.693 | 0.932 | - | 0.981 | 0.780 | - | - | Mlig455_013974 {REF} {Length: 857} {RNA1509_4527} {RNA1310_27536} {RNA815_19650} Mlig455_034999 {REF} {Length: 847} {RNA1509_4527} {RNA1310_27536} {RNA815_19650} |
|
44. | MligTC455_28722 | 5157 | 107.43 | Mlig455_054221 | Neo: - Age: Down-Down-Up Region-specific R2: 4.518 Region-enriched R2: 3.867/0.00001 |
2.69 | 0.922 | - | 0.956 | 0.812 | - | - | Mlig455_054221 {REF} {Length: 1624} {RNA1509_14080, RNA1509_47772} {RNA1310_32043.1, RNA1509_47772} {RNA1509_47772, RNA815_14905} | |
45. | MligTC455_50827 | 107 | 2.22 | Mlig455_037867 | Neo: - |
WSCD2 | 2.684 | 0.749 | - | 0.967 | 0.968 | - | - | Mlig455_037867 {REF} {Length: 912} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=50.4, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=53.9, Expect=4e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.9, Expect=2e-08]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=46.2, Expect=8e-06]} {RNA1509_59284} {RNA1310_52794.1} {RNA815_21749.1} |
46. | MligTC455_08884 | 27 | 0.57 | Mlig455_053794, Mlig455_068544 | Neo: - Age: - |
SCNN1B | 2.678 | 0.861 | - | - | 0.973 | 0.844 | - | Mlig455_053794 {REF} {Length: 1923} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=170.4]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=73.9, Expect=3e-13]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=72.4, Expect=6e-13]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=62.4, Expect=6e-10]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=86.3, Expect=1e-17]} {RNA1509_31312} {RNA1310_35950} {RNA815_20662} Mlig455_068544 {REF} {Length: 2256} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=170.9]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=73.9, Expect=4e-13]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=72.4, Expect=7e-13]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=62.0, Expect=7e-10]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=85.1, Expect=3e-17]} {RNA1509_31137} {RNA1310_35950} {RNA815_20662} |
47. | MligTC455_28721 | 5194 | 108.2 | Mlig455_032217 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=0.434 Region-specific R2: 4.415 Region-enriched R2: 3.899/0.00001 |
2.662 | 0.911 | - | 0.955 | 0.796 | - | - | Mlig455_032217 {REF} {Length: 1138} {RNA1509_13111, RNA1509_14080, RNA1509_28175, RNA1509_53802, RNA1509_7170} {RNA1310_32043.1, RNA1509_13111, RNA1509_28175, RNA1509_53802, RNA1509_7170} {RNA1509_13111, RNA1509_28175, RNA1509_53802, RNA1509_7170, RNA815_14905} | |
48. | MligTC455_41721 | 1545 | 32.19 | Mlig455_000238 | Neo: - Age: logFC(26M/2M)=1.827 Region-enriched R2: 7.263/0.00002 |
2.659 | - | 0.986 | 0.930 | 0.743 | - | - | Mlig455_000238 {REF} {Length: 600} {RNA1509_17403} {RNA1310_82552.1} {RNA815_43140.1} | |
49. | MligTC455_33814 | 559 | 11.65 | Mlig455_061944 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.446/0.00053 |
MOXD1 | 2.653 | 0.836 | - | 0.829 | 0.988 | - | - | Mlig455_061944 {REF} {Length: 2816} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=105.5]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=67.8]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=129, Expect=2e-31]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=141, Expect=1e-35]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=116, Expect=3e-27]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=129, Expect=9e-32]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=120, Expect=7e-30]} {RNA1509_41983} {RNA1310_8990, RNA1509_41983} {RNA1509_41983, RNA815_3230} |
50. | MligTC455_13165 | 181 | 3.77 | Mlig455_018648 | Neo: - Age: - Region-specific R2: 6.131 Region-enriched R2: 4.463/0.01828 Regeneration-downregulated R2: -3.253 Regeneration-depleted R2: -3.253 |
2.651 | 0.933 | - | 0.747 | 0.971 | - | - | Mlig455_018648 {REF} {Length: 1920} {TRANSSPLICED} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_25789} {RNA1310_15994} {RNA815_21830} | |
51. | MligTC455_15332 | 44 | 0.93 | Mlig455_062622, Mlig455_067527 | Neo: - Age: - Region-enriched R2: 7.516/0.00418 |
ASIC4 | 2.65 | 0.985 | - | 0.894 | 0.771 | - | - | Mlig455_062622 {REF} {Length: 2228} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=73.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=47.4, Expect=7e-06]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=51.6, Expect=2e-07]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=55.8, Expect=3e-09]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.1, Expect=2e-08]} {RNA1310_17847} {RNA815_27317} Mlig455_067527 {REF} {Length: 1916} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=147.3]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=50.1, Expect=1e-05]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=50.8, Expect=3e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.5, Expect=2e-07]} {RNA1310_17847} {RNA815_27317} |
52. | MligTC455_12117 | 38 | 0.78 | Mlig455_013500 | Neo: - Age: - |
2.647 | 0.982 | - | 0.787 | 0.878 | - | - | Mlig455_013500 {REF} {Length: 2103} {RNA1310_23237} {RNA815_45659} | |
53. | MligTC455_12116 | 106 | 2.2 | Mlig455_004661, Mlig455_004728 | Neo: - Age: Up-Up-Down |
2.641 | - | 0.981 | 0.950 | - | 0.710 | - | Mlig455_004661 {REF} {Length: 3441} {RNA1509_48407} {RNA1310_2938.1} {RNA815_14343.2} Mlig455_004728 {REF} {Length: 2670} {RNA1509_48407} {RNA1310_45267.1, RNA1509_48407} {RNA1509_48407, RNA815_58661} |
|
54. | MligTC455_53758 | 4602 | 95.88 | Mlig455_016119, Mlig455_044593 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.845 Region-enriched R2: 6.352/0.00005 |
2.64 | 0.742 | - | 0.933 | 0.965 | - | - | Mlig455_016119 {REF} {Length: 484} {RNA1509_10966} {RNA1310_38782} {RNA815_8445.1} Mlig455_044593 {REF} {Length: 718} {Pfam: ATP synthase subunit K [PF11022.10, score=19.3]} {RNA1509_10966} {RNA1310_38782} {RNA815_8445.1} |
|
55. | MligTC455_13166 | 186 | 3.88 | Mlig455_018849 | Neo: - Age: - Region-specific R2: 6.227 |
2.636 | 0.911 | - | 0.754 | 0.971 | - | - | Mlig455_018849 {REF} {Length: 693} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_49819} {RNA1310_28647} {RNA815_1682.1} | |
56. | MligTC455_18771 | 659 | 13.72 | Mlig455_016920, Mlig455_017020 | Neo: - Age: - Region-enriched R2: 5.606/0.00193 |
2.636 | - | - | 0.983 | 0.861 | 0.792 | - | Mlig455_016920 {REF} {Length: 860} {RNA1509_33769} {RNA1310_80187.1} {RNA815_43341.1} Mlig455_017020 {REF} {Length: 769} {RNA1509_33769} {RNA1310_80187.1, RNA1509_33769} {RNA1509_33769, RNA815_43341.1} |
|
57. | MligTC455_32554 | 51 | 1.07 | Mlig455_024179 | Neo: - Age: - |
2.635 | 0.967 | - | 0.863 | 0.805 | - | - | Mlig455_024179 {REF} {Length: 926} {RNA1509_24504} {RNA1310_3168} {RNA815_18309} | |
58. | MligTC455_34692 | 37 | 0.77 | Mlig455_017379 | Neo: - Age: - |
2.632 | 0.992 | - | 0.781 | 0.859 | - | - | Mlig455_017379 {REF} {Length: 579} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_10294} {RNA1310_2672} {RNA815_25099} | |
59. | MligTC455_44189 | 30 | 0.63 | Mlig455_020227 | Neo: - Age: - |
APLNR | 2.63 | - | 0.775 | 0.879 | 0.976 | - | - | Mlig455_020227 {REF} {Length: 2245} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=51.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=35.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=21.0]} {Human: ENSG00000134817, APLNR, apelin receptor, [Score=54.3, Expect=2e-07]} {Mouse: ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=94.0, Expect=4e-20]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=87.0, Expect=4e-18]} {Smed: dd_Smed_v6_31203_0_1, dd_Smed_v6_31203_0_1, [Score=167, Expect=2e-46]} {RNA1310_43286} {RNA815_36082} |
60. | MligTC455_06200 | 8 | 0.17 | Mlig455_022367 | Neo: - Age: - |
2.628 | 0.971 | - | 0.740 | 0.917 | - | - | Mlig455_022367 {REF} {Length: 738} {Pfam: WSC domain [PF01822.21, score=44.0]; PAN domain [PF00024.28, score=20.8]} {RNA1310_89673} {RNA815_64813} | |
61. | MligTC455_43851 | 79 | 1.64 | Mlig455_031738 | Neo: - Age: - |
PI16 | 2.602 | 0.746 | - | 0.873 | 0.983 | - | - | Mlig455_031738 {REF} {Length: 2697} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=65.5]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=82.4, Expect=4e-16]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=83.2, Expect=2e-16]} {Dmel: FBgn0038126, CG8483, [Score=48.5, Expect=9e-06]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.0, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=139, Expect=3e-35]} {RNA1509_36211} {RNA1310_15740, RNA1509_36211} {RNA1509_36211, RNA815_1860.1} |
62. | MligTC455_04170 | 65 | 1.36 | Mlig455_000555, Mlig455_030353 | Neo: - Age: - |
FGG | 2.586 | 0.983 | - | 0.864 | 0.739 | - | - | Mlig455_000555 {REF} {Length: 1133} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=125.0]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=103, Expect=3e-24]; ENSG00000120332, TNN, tenascin N, [Score=98.2, Expect=3e-22]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=102, Expect=6e-25]; ENSMUSG00000026938, Fcna, ficolin A, [Score=99.4, Expect=1e-23]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=98.2, Expect=9e-23]; ENSMUSG00000026725, Tnn, tenascin N, [Score=98.2, Expect=2e-22]} {Dmel: FBgn0051832, CG31832, [Score=88.2, Expect=2e-20]} {Celegans: WBGene00020516, T15B7.1, [Score=62.4, Expect=8e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=72.4, Expect=4e-14]} {RNA1310_33683.2} {RNA815_41841} Mlig455_030353 {REF} {Length: 1214} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.3]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=103, Expect=3e-24]; ENSG00000120332, TNN, tenascin N, [Score=99.4, Expect=3e-22]; ENSG00000160339, FCN2, ficolin 2, [Score=98.2, Expect=6e-23]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=102, Expect=1e-24]; ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=1e-23]; ENSMUSG00000026725, Tnn, tenascin N, [Score=99.0, Expect=2e-22]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=99.0, Expect=9e-23]} {Dmel: FBgn0051832, CG31832, [Score=92.0, Expect=9e-22]} {Celegans: WBGene00020516, T15B7.1, [Score=63.2, Expect=4e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=75.9, Expect=4e-15]} {RNA1310_33683.2} {RNA815_41841} |
63. | MligTC455_53633 | 1960 | 40.84 | Mlig455_043831, Mlig455_047417, Mlig455_070992 | Neo: - Age: - Region-specific R2: 8.211 Region-enriched R2: 9.874/0.00000 |
2.586 | 0.704 | - | 0.894 | 0.988 | - | - | Mlig455_043831 {REF} {Length: 1456} {RNA1509_16856} {RNA1310_25970.1, RNA1509_16856} {RNA1509_16856, RNA815_11970} Mlig455_047417 {REF} {Length: 1354} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} Mlig455_070992 {REF} {Length: 1455} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} |
|
64. | MligTC455_23101 | 397 | 8.28 | Mlig455_048080 | Neo: - Age: - Region-enriched R2: 3.122/0.00807 |
2.583 | 0.972 | - | 0.739 | 0.872 | - | - | Mlig455_048080 {REF} {Length: 721} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452, RNA1509_16955} {RNA1509_16955, RNA815_4585} | |
65. | MligTC455_51304 | 78 | 1.63 | Mlig455_027579 | Neo: - Age: - |
CTSA | 2.581 | - | 0.791 | 0.831 | 0.959 | - | - | Mlig455_027579 {REF} {Length: 3047} {Pfam: Serine carboxypeptidase [PF00450.24, score=324.1]} {Human: ENSG00000064601, CTSA, cathepsin A, [Score=178, Expect=3e-48]} {Mouse: ENSMUSG00000017760, Ctsa, cathepsin A, [Score=175, Expect=2e-47]} {Dmel: FBgn0038738, CG4572, [RH, Score=120, Expect=8e-29]} {Celegans: WBGene00019605, ctsa-1, Uncharacterized serine carboxypeptidase ctsa-1, [Score=197, Expect=6e-56]} {Smed: dd_Smed_v6_785_0_1, dd_Smed_v6_785_0_1, [Score=203, Expect=1e-57]} {RNA1310_57245} {RNA815_58201} |
66. | MligTC455_05494 | 51 | 1.06 | Mlig455_004276, Mlig455_004287, Mlig455_004362 | Neo: - Age: - |
2.572 | - | 0.981 | 0.740 | 0.851 | - | - | Mlig455_004276 {REF} {Length: 1694} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=48.1]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.2]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [RH, Score=151, Expect=1e-41]} {RNA1310_39315} {RNA815_27280} Mlig455_004287 {REF} {Length: 4218} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=48.1]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.2]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [RH, Score=151, Expect=1e-41]} {RNA1509_28642} {RNA1310_39315} {RNA815_27280} Mlig455_004362 {REF} {Length: 400} {NoTransDecoderORF} {RNA1310_149581} |
|
67. | MligTC455_46581 | 31 | 0.64 | Mlig455_042524 | Neo: - Age: - |
2.564 | 1.000 | - | 0.821 | 0.743 | - | - | Mlig455_042524 {REF} {Length: 975} {RNA1509_46101} {RNA1310_32444} {RNA815_42659} | |
68. | MligTC455_31333 | 577 | 12.03 | Mlig455_015221 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.948/0.00003 |
2.563 | 0.807 | 0.968 | - | - | 0.788 | - | Mlig455_015221 {REF} {Length: 722} {RNA1509_15363, RNA1509_24781} {RNA1310_37267, RNA1509_15363, RNA1509_24781} {RNA1509_15363, RNA1509_24781, RNA815_31275} | |
69. | MligTC455_23099 | 185 | 3.85 | Mlig455_048061 | Neo: - |
2.562 | 0.752 | - | 0.829 | 0.981 | - | - | Mlig455_048061 {REF} {Length: 713} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452} {RNA815_4585} | |
70. | MligTC455_43981 | 82 | 1.71 | Mlig455_043913 | Neo: - Age: logFC(26M/2M)=-0.628 |
2.562 | 0.961 | - | 0.759 | 0.842 | - | - | Mlig455_043913 {REF} {Length: 3235} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=165.2]} {Dmel: FBgn0039679, ppk19, pickpocket 19, [Score=53.9, Expect=3e-07]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=56.2, Expect=5e-08]} {Smed: dd_Smed_v6_16557_0_1, dd_Smed_v6_16557_0_1, [Score=72.0, Expect=3e-13]} {RNA1310_43117} {RNA815_28951} | |
71. | MligTC455_43561 | 47 | 0.98 | Mlig455_019076, Mlig455_064291 | Neo: - Age: - |
ASIC3 | 2.561 | 0.976 | - | 0.705 | 0.880 | - | - | Mlig455_019076 {REF} {Length: 2496} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=274.8]} {Human: ENSG00000213199, ASIC3, acid sensing ion channel subunit 3, [RH, Score=122, Expect=5e-29]} {Mouse: ENSMUSG00000020704, Asic2, acid-sensing (proton-gated) ion channel 2, [Score=114, Expect=1e-26]} {Dmel: FBgn0030795, ppk28, pickpocket 28, [Score=58.5, Expect=9e-09]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=133, Expect=5e-33]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [Score=127, Expect=4e-31]} {RNA1509_37765} {RNA1310_15854} {RNA815_39159} Mlig455_064291 {REF} {Length: 2206} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=52.6]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=46.6, Expect=1e-06]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=47.8, Expect=1e-07]} {RNA1509_37765} {RNA1310_15854} {RNA815_28789} |
72. | MligTC455_50255 | 777 | 16.18 | Mlig455_018293 | Neo: - Age: Down-Up-Up Region-enriched R2: 1.926/0.01583 |
2.551 | 0.819 | 0.781 | 0.951 | - | - | - | Mlig455_018293 {REF} {Length: 691} {Smed: dd_Smed_v6_8966_0_1, dd_Smed_v6_8966_0_1, [RH, Score=70.9, Expect=1e-16]} {RNA1509_37352} {RNA1310_62086} {RNA815_22267.2} | |
73. | MligTC455_20017 | 520 | 10.83 | Mlig455_041990 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.348/0.00021 |
2.485 | - | 0.729 | 0.770 | 0.986 | - | - | Mlig455_041990 {REF} {Length: 965} {Pfam: EF-hand domain [PF13405.8, score=60.3]; EF hand [PF00036.34, score=52.6]; EF-hand domain pair [PF13499.8, score=49.5]; EF hand [PF13202.8, score=40.2]; EF-hand domain [PF14658.8, score=30.6]; EF-hand domain pair [PF13833.8, score=30.2]} {Dmel: FBgn0052103, CG32103, [Score=43.5, Expect=1e-05]} {Smed: dd_Smed_v6_16347_0_2, dd_Smed_v6_16347_0_2, [Score=67.8, Expect=1e-15]} {RNA1509_17125, RNA1509_31091} {RNA1310_56976, RNA1509_17125, RNA1509_31091} {RNA1509_17125, RNA1509_31091, RNA815_29327} | |
74. | MligTC455_47197 | 155 | 3.24 | Mlig455_049096, Mlig455_049118 | Neo: - Age: - |
2.481 | 0.746 | 0.958 | 0.777 | - | - | - | Mlig455_049096 {REF} {Length: 3209} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=151, Expect=1e-37]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} Mlig455_049118 {REF} {Length: 3116} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=160, Expect=1e-40]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} |
|
75. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 2.481 | - | 1.000 | 0.754 | 0.727 | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
76. | MligTC455_18772 | 530 | 11.04 | Mlig455_016933, Mlig455_017024 | Neo: - Age: logFC(26M/2M)=-0.938 Region-enriched R2: 6.558/0.00256 |
2.464 | 0.734 | - | 0.983 | - | 0.747 | - | Mlig455_016933 {REF} {Length: 853} {RNA1509_33769} {RNA1310_80187.1} {RNA815_43341.1} Mlig455_017024 {REF} {Length: 476} {RNA1509_33769} {RNA1310_80187.1} {RNA815_43341.1} |
|
77. | MligTC455_02494 | 237 | 4.93 | Mlig455_004106 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.703/0.00228 |
2.459 | - | 0.957 | 0.778 | 0.724 | - | - | Mlig455_004106 {REF} {Length: 917} {RNA1509_21522, RNA1509_4995} {RNA1310_15694.2, RNA1509_21522} {RNA1509_21522, RNA815_5222} | |
78. | MligTC455_11788 | 20 | 0.41 | Mlig455_043729, Mlig455_043819, Mlig455_047429 | Neo: - Age: - |
ANGPTL1 | 1.983 | 1.000 | - | - | 0.983 | - | - | Mlig455_043729 {REF} {Length: 1137} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=144.4]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=131, Expect=2e-34]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=129, Expect=9e-34]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=127, Expect=5e-33]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=134, Expect=9e-36]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=131, Expect=8e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=129, Expect=8e-34]} {Dmel: FBgn0003326, sca, scabrous, [Score=119, Expect=4e-30]} {Celegans: WBGene00017013, ensh-1, [Score=46.6, Expect=1e-05]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=110, Expect=4e-27]} {RNA1509_26827} {RNA1310_41424} {RNA815_48855} Mlig455_043819 {REF} {Length: 1111} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=143.1]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=129, Expect=1e-33]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=127, Expect=4e-33]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=125, Expect=2e-32]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=132, Expect=5e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=130, Expect=3e-34]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=127, Expect=4e-33]} {Dmel: FBgn0003326, sca, scabrous, [Score=117, Expect=2e-29]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=108, Expect=2e-26]} {RNA1509_26827} {RNA1310_41424} {RNA815_48855} Mlig455_047429 {REF} {Length: 1072} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=143.1]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=129, Expect=1e-33]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=127, Expect=4e-33]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=125, Expect=2e-32]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=132, Expect=5e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=130, Expect=3e-34]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=127, Expect=4e-33]} {Dmel: FBgn0003326, sca, scabrous, [Score=117, Expect=2e-29]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=108, Expect=2e-26]} {RNA1509_26827} {RNA1310_41424} {RNA815_48855} |
79. | MligTC455_46044 | 61 | 1.26 | Mlig455_047114 | Neo: - Age: - |
1.974 | - | - | 0.985 | 0.989 | - | - | Mlig455_047114 {REF} {Length: 1814} {Pfam: WSC domain [PF01822.21, score=46.9]; PAN domain [PF00024.28, score=20.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=46.2, Expect=1e-05]} {RNA1509_32911} {RNA1310_59750} {RNA815_37535} | |
80. | MligTC455_41011 | 90 | 1.87 | Mlig455_014030, Mlig455_014036 | Neo: - Age: Down-Up-Down |
1.973 | - | - | 0.988 | 0.985 | - | - | Mlig455_014030 {REF} {Length: 1659} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=41.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=36.2]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=95.1, Expect=2e-21]} {RNA1310_70554} {RNA815_47734} Mlig455_014036 {REF} {Length: 1980} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=51.3]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.7]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=104, Expect=3e-24]} {RNA1310_70554} {RNA815_47734} |
|
81. | MligTC455_20382 | 62 | 1.28 | Mlig455_032572 | Neo: - |
1.969 | - | - | 0.986 | 0.983 | - | - | Mlig455_032572 {REF} {Length: 520} {RNA1509_48296} {RNA1310_86641, RNA1509_48296} {RNA1509_48296, RNA815_40392} | |
82. | MligTC455_33877 | 47 | 0.97 | Mlig455_053914 | Neo: - |
PKD1L2 | 1.961 | - | - | 0.980 | 0.981 | - | - | Mlig455_053914 {REF} {Length: 11153} {Pfam: Polycystin cation channel [PF08016.14, score=263.3]; PKD domain [PF18911.2, score=78.1]; PLAT/LH2 domain [PF01477.25, score=77.6]; PKD domain [PF00801.22, score=77.5]; REJ domain [PF02010.17, score=51.1]; Ion transport protein [PF00520.33, score=32.5]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=236, Expect=4e-61]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=254, Expect=1e-66]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=132, Expect=3e-30]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=134, Expect=1e-30]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=451, Expect=4e-127]} {RNA1509_40400} {RNA1310_23183} {RNA815_27645} |
83. | MligTC455_33442 | 39 | 0.81 | Mlig455_039767 | Neo: - Age: - |
1.958 | 0.982 | - | - | 0.976 | - | - | Mlig455_039767 {REF} {Length: 1975} {RNA1310_42391} | |
84. | MligTC455_16838 | 75 | 1.57 | Mlig455_030118, Mlig455_030184 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=1.009 Region-enriched R2: 5.681/0.04612 |
1.936 | - | - | 0.976 | 0.960 | - | - | Mlig455_030118 {REF} {Length: 1426} {RNA1310_40798} {RNA815_26160} Mlig455_030184 {REF} {Length: 1426} {RNA1310_40798} {RNA815_26160} |
|
85. | MligTC455_21178 | 29 | 0.59 | Mlig455_001203, Mlig455_066754, Mlig455_069710 | Neo: - Age: Down-Up-Down |
CCKAR, NPFFR1 | 1.936 | - | 0.953 | - | 0.983 | - | - | Mlig455_001203 {REF} {Length: 4789} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=109.9]} {Human: ENSG00000163394, CCKAR, cholecystokinin A receptor, [Score=60.5, Expect=3e-09]; ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=58.5, Expect=9e-09]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=59.3, Expect=3e-09]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=58.2, Expect=4e-09]; ENSMUSG00000029193, Cckar, cholecystokinin A receptor, [Score=56.6, Expect=3e-08]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=56.6, Expect=2e-08]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=65.5, Expect=4e-11]} {Celegans: WBGene00004778, ser-3, SERotonin/octopamine receptor family, [Score=58.5, Expect=5e-09]} {Smed: dd_Smed_v6_43180_0_1, dd_Smed_v6_43180_0_1, [Score=72.4, Expect=4e-14]} {RNA1310_113134} Mlig455_066754 {REF} {Length: 3197} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=84.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=52.8, Expect=6e-07]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=53.5, Expect=2e-07]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=50.1, Expect=1e-06]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=52.8, Expect=2e-07]} {RNA1310_131269} Mlig455_069710 {REF} {Length: 1208} {NoTransDecoderORF} {RNA1310_131269} |
86. | MligTC455_22501 | 73 | 1.51 | Mlig455_036417 | Neo: - |
SLC6A4 | 1.936 | - | - | 0.953 | 0.983 | - | - | Mlig455_036417 {REF} {Length: 3681} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=681.8]} {Human: ENSG00000108576, SLC6A4, solute carrier family 6 member 4, [RH, Score=610, Expect=0.0]} {Mouse: ENSMUSG00000020838, Slc6a4, solute carrier family 6 (neurotransmitter transporter, serotonin), member 4, [RH, Score=599, Expect=0.0]} {Dmel: FBgn0010414, SerT, Serotonin transporter, [RH, Score=631, Expect=0.0]} {Celegans: WBGene00003387, mod-5, Transporter, [RH, Score=559, Expect=0.0]} {Smed: dd_Smed_v6_12700_0_1, dd_Smed_v6_12700_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_33614} {RNA1310_10815, RNA1509_33614} {RNA1509_33614, RNA815_8003} |
87. | MligTC455_18161 | 771 | 16.05 | Mlig455_031626, Mlig455_048205 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.318/0.00160 |
1.935 | 0.977 | - | - | 0.958 | - | - | Mlig455_031626 {REF} {Length: 835} {TRANSSPLICED} {RNA1509_48514} {RNA1310_56583, RNA1509_48514} {RNA1509_48514, RNA815_34758} Mlig455_048205 {REF} {Length: 651} {RNA1509_48514} {RNA1310_56583} {RNA815_34758} |
|
88. | MligTC455_48358 | 291 | 6.07 | Mlig455_009342, Mlig455_036996 | Neo: - Age: - Region-specific R2: 6.920 Region-enriched R2: 5.581/0.00062 |
FOXA2 | 1.929 | - | - | 0.955 | 0.974 | - | - | Mlig455_009342 {REF} {Length: 3571} {Pfam: Forkhead domain [PF00250.20, score=129.1]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [RH, Score=237, Expect=2e-71]; ENSG00000129514, FOXA1, forkhead box A1, [RH, Score=231, Expect=3e-69]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [RH, Score=243, Expect=5e-74]; ENSMUSG00000035451, Foxa1, forkhead box A1, [RH, Score=231, Expect=2e-69]} {Dmel: FBgn0000659, fkh, fork head, [RH, Score=245, Expect=1e-72]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [RH, Score=204, Expect=6e-59]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [RH, Score=246, Expect=3e-75]} {RNA1509_57651} {RNA1310_8486.1} {RNA815_24959.1} Mlig455_036996 {REF} {Length: 3801} {Pfam: Forkhead domain [PF00250.20, score=129.0]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [RH, Score=237, Expect=1e-71]; ENSG00000129514, FOXA1, forkhead box A1, [RH, Score=231, Expect=3e-69]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [RH, Score=243, Expect=5e-74]; ENSMUSG00000035451, Foxa1, forkhead box A1, [RH, Score=231, Expect=2e-69]} {Dmel: FBgn0000659, fkh, fork head, [RH, Score=245, Expect=1e-72]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [RH, Score=204, Expect=7e-59]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [RH, Score=246, Expect=3e-75]} {RNA1509_57651} {RNA1310_8486.1, RNA1509_57651} {RNA1509_57651, RNA815_24959.1} |
89. | MligTC455_11722 | 10 | 0.21 | Mlig455_017551 | Neo: - Age: - |
ASIC5 | 1.923 | 0.940 | - | - | 0.983 | - | - | Mlig455_017551 {REF} {Length: 1968} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=199.9]} {Human: ENSG00000256394, ASIC5, acid sensing ion channel subunit family member 5, [Score=65.9, Expect=1e-10]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=69.7, Expect=5e-12]} {Celegans: WBGene00006748, unc-8, Degenerin unc-8, [Score=73.2, Expect=2e-13]} {Smed: dd_Smed_v6_34707_0_1, dd_Smed_v6_34707_0_1, [Score=95.1, Expect=2e-20]} {RNA1310_93171} |
90. | MligTC455_53937 | 44 | 0.92 | Mlig455_021975, Mlig455_022028 | Neo: - Age: - |
1.922 | 0.979 | - | 0.943 | - | - | - | Mlig455_021975 {REF} {Length: 631} {NoTransDecoderORF} {RNA1310_130902} Mlig455_022028 {REF} {Length: 192} {NoTransDecoderORF} {RNA1310_130902} |
|
91. | MligTC455_16780 | 59 | 1.22 | Mlig455_003112, Mlig455_062777 | Neo: - Age: - |
1.917 | - | - | 0.965 | 0.952 | - | - | Mlig455_003112 {REF} {Length: 1644} {Pfam: PAN domain [PF14295.8, score=23.1]} {RNA1509_48973} {RNA1310_82250} {RNA815_43010} Mlig455_062777 {REF} {Length: 1721} {RNA1509_48973} {RNA1310_82250} {RNA815_43010} |
|
92. | MligTC455_41854 | 80 | 1.67 | Mlig455_034307, Mlig455_067305, Mlig455_067321 | Neo: - Age: - |
1.914 | - | 0.927 | 0.987 | - | - | - | Mlig455_034307 {REF} {Length: 459} {RNA815_51696.1} Mlig455_067305 {REF} {Length: 466} {RNA815_51696.1} Mlig455_067321 {REF} {Length: 95} {TRANSSPLICED} {NoTransDecoderORF} {RNA815_51696.1} |
|
93. | MligTC455_17644 | 182 | 3.8 | Mlig455_007930, Mlig455_008033 | Neo: - Age: - |
1.911 | 0.944 | - | - | 0.967 | - | - | Mlig455_007930 {REF} {Length: 2086} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.9]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=3e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} Mlig455_008033 {REF} {Length: 1974} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.6]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=4e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} |
|
94. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
1.911 | 0.928 | 0.983 | - | - | - | - | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
95. | MligTC455_51260 | 90 | 1.88 | Mlig455_009349 | Neo: - Age: - |
1.907 | - | - | 0.946 | 0.961 | - | - | Mlig455_009349 {REF} {Length: 1657} {Pfam: Universal stress protein family [PF00582.28, score=83.5]} {Smed: dd_Smed_v6_402_1_1, dd_Smed_v6_402_1_1, [Score=97.8, Expect=2e-24]} {RNA1310_30400} {RNA815_28361} | |
96. | MligTC455_42217 | 16 | 0.34 | Mlig455_035749 | Neo: - Age: - |
OSR1 | 1.906 | - | - | 0.923 | 0.983 | - | - | Mlig455_035749 {REF} {Length: 1970} {Human: ENSG00000143867, OSR1, odd-skipped related transciption factor 1, [Score=55.8, Expect=3e-08]; ENSG00000164920, OSR2, odd-skipped related transciption factor 2, [Score=53.9, Expect=1e-07]} {Mouse: ENSMUSG00000048387, Osr1, odd-skipped related transcription factor 1, [Score=56.2, Expect=2e-08]; ENSMUSG00000022330, Osr2, odd-skipped related 2, [Score=54.3, Expect=8e-08]} {Dmel: FBgn0002985, odd, odd skipped, [Score=53.1, Expect=2e-07]} {Celegans: WBGene00003846, odd-2, Protein odd-skipped-related 2, [Score=54.3, Expect=3e-08]} {Smed: dd_Smed_v6_10039_0_1, dd_Smed_v6_10039_0_1, [Score=57.8, Expect=2e-09]} {RNA1509_57522} {RNA1310_26149} {RNA815_39133} |
97. | MligTC455_53759 | 2456 | 51.16 | Mlig455_016120 | Neo: - Age: logFC(26M/2M)=-1.068 Region-enriched R2: 6.391/0.00020 |
1.906 | - | - | 0.959 | 0.947 | - | - | Mlig455_016120 {REF} {Length: 573} {RNA1509_10966, RNA1509_2075, RNA1509_23631, RNA1509_5413, RNA1509_5649} {RNA1310_97571, RNA1509_2075, RNA1509_23631, RNA1509_5413, RNA1509_5649} {RNA1509_2075, RNA1509_23631, RNA1509_5413, RNA1509_5649, RNA815_8445.4} | |
98. | MligTC455_44027 | 2077 | 43.27 | Mlig455_023794, Mlig455_066345 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.334/0.00002 |
1.904 | - | - | 0.955 | 0.949 | - | - | Mlig455_023794 {REF} {Length: 4844} {RNA1509_18615} {RNA1310_25864.1, RNA1509_18615} {RNA1509_18615, RNA815_25315} Mlig455_066345 {REF} {Length: 5051} {RNA1509_18615, RNA1509_45291} {RNA1310_25864.1, RNA1509_45291} {RNA1509_45291, RNA815_25315} |
|
99. | MligTC455_17175 | 78 | 1.62 | Mlig455_042330, Mlig455_047110 | Neo: - Age: - |
GABRA6 | 1.899 | 0.976 | - | - | 0.923 | - | - | Mlig455_042330 {REF} {Length: 1845} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=104.1]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=236, Expect=1e-72]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=229, Expect=4e-69]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=241, Expect=9e-75]} {Dmel: FBgn0030707, CG8916, [Score=248, Expect=4e-77]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=227, Expect=2e-69]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=242, Expect=6e-76]} {RNA1310_60750} {RNA815_41846} Mlig455_047110 {REF} {Length: 1843} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=138.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.4]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=248, Expect=4e-76]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=246, Expect=4e-74]; ENSG00000151834, GABRA2, gamma-aminobutyric acid type A receptor alpha2 subunit, [Score=243, Expect=4e-74]; ENSG00000186297, GABRA5, gamma-aminobutyric acid type A receptor alpha5 subunit, [Score=242, Expect=1e-73]; ENSG00000011677, GABRA3, gamma-aminobutyric acid type A receptor alpha3 subunit, [Score=239, Expect=3e-72]; ENSG00000022355, GABRA1, gamma-aminobutyric acid type A receptor alpha1 subunit, [Score=239, Expect=2e-72]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=236, Expect=2e-71]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=254, Expect=1e-78]; ENSMUSG00000029211, Gabra4, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4, [Score=244, Expect=1e-73]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [Score=244, Expect=1e-74]; ENSMUSG00000000560, Gabra2, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2, [Score=243, Expect=4e-74]} {Dmel: FBgn0030707, CG8916, [Score=268, Expect=2e-83]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=252, Expect=1e-77]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=263, Expect=1e-82]} {RNA1310_60750} {RNA815_41846} |
100. | MligTC455_41762 | 102 | 2.13 | Mlig455_032244 | Neo: - |
KREMEN2 | 1.897 | - | - | 0.935 | 0.962 | - | - | Mlig455_032244 {REF} {Length: 1054} {Pfam: WSC domain [PF01822.21, score=60.0]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.0, Expect=3e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]; ENSMUSG00000020811, Wscd1, WSC domain containing 1, [Score=50.4, Expect=8e-07]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=48.9, Expect=3e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=57.4, Expect=4e-09]} {RNA1509_59284} {RNA1310_42674} {RNA815_21749.1} |